Showing results (251-260 of 341) with videos related to
Sort By:
Pageof 35
Clinical Cardiology|November 4, 2020
Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarctionJosé C Nicolau, David Brieger, Ruth Owen, et al.JACC. Cardiovascular Interventions|October 25, 2014
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot studyJosep Rodés-Cabau, Philip Kahlert, Franz-Josef Neumann, et al.The New England Journal of Medicine|November 19, 2009
Ferric carboxymaltose in patients with heart failure and iron deficiencyStefan D Anker, Josep Comin Colet, Gerasimos Filippatos, et al.Annals of Emergency Medicine|January 28, 2019
Effect of Barthel Index on the Risk of Thirty-Day Mortality in Patients With Acute Heart Failure Attending the Emergency Department: A Cohort Study of Nine Thousand Ninety-Eight Patients From the Epidemiology of Acute Heart Failure in Emergency Departments RegistryXavier Rossello, Òscar Miró, Pere Llorens, et al.Journal of the American College of Cardiology|August 30, 2008
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, E Magnus Ohman, A Michael Lincoff, et al.Annals of Emergency Medicine|June 1, 2019
Analysis of How Emergency Physicians' Decisions to Hospitalize or Discharge Patients With Acute Heart Failure Match the Clinical Risk Categories of the MEESSI-AHF ScaleÒscar Miró, Xavier Rossello, Víctor Gil, et al.JACC. Heart Failure|September 16, 2023
Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-ReducedNitish K Dhingra, Subodh Verma, Javed Butler, et al.Journal of Cardiac Failure|August 9, 2023
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced TrialMuhammad Shahzeb Khan, Stefan D Anker, Gerasimos Filippatos, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trialArie Pieter Kappetein, Patrick W Serruys, Joseph F Sabik, et al.European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.Pageof 35